François Picard

3.2k total citations · 1 hit paper
54 papers, 1.5k citations indexed

About

François Picard is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Sociology and Political Science. According to data from OpenAlex, François Picard has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 18 papers in Pulmonary and Respiratory Medicine and 5 papers in Sociology and Political Science. Recurrent topics in François Picard's work include Pulmonary Hypertension Research and Treatments (16 papers), Heart Failure Treatment and Management (13 papers) and Cardiovascular Function and Risk Factors (9 papers). François Picard is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Heart Failure Treatment and Management (13 papers) and Cardiovascular Function and Risk Factors (9 papers). François Picard collaborates with scholars based in France, Canada and United Kingdom. François Picard's co-authors include Olivier Sitbon, David Montani, Xavier Jaïs, Marc Humbert, Emmanuel Bergot, Pascal de Groote, Grégoire Prévôt, Ari Chaouat, Vincent Cottin and Arnaud Bourdin and has published in prestigious journals such as Circulation Research, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

François Picard

46 papers receiving 1.5k citations

Hit Papers

Risk assessment, prognosis and guideline implementation i... 2017 2026 2020 2023 2017 100 200 300 400

Peers

François Picard
François Picard
Citations per year, relative to François Picard François Picard (= 1×) peers Gilles Garcia

Countries citing papers authored by François Picard

Since Specialization
Citations

This map shows the geographic impact of François Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Picard more than expected).

Fields of papers citing papers by François Picard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Picard. The network helps show where François Picard may publish in the future.

Co-authorship network of co-authors of François Picard

This figure shows the co-authorship network connecting the top 25 collaborators of François Picard. A scholar is included among the top collaborators of François Picard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Picard. François Picard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouleti, Claire, Benjamin Alos, Damien Legallois, et al.. (2024). Rationale and design of the French Observatory of Acute Heart Failure (OFICA2). Archives of cardiovascular diseases. 117(8-9). 514–520.
2.
Boucly, Athénaïs, Antoine Beurnier, Ségolène Turquier, et al.. (2024). Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension. European Respiratory Journal. 64(3). 2400197–2400197. 13 indexed citations
3.
Nougue, Hélène, Michel Thibault, François Picard, et al.. (2023). Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment. Clinical Chemistry. 69(4). 350–362. 2 indexed citations
4.
Thibault, Michel, Hélène Nougue, Guillaume Lefèvre, et al.. (2022). proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action. Circulation Research. 130(11). e44–e57. 5 indexed citations
5.
Cohen‐Solal, Alain, François Picard, Nicolas Delarche, et al.. (2022). Iron Deficiency in Heart Failure Patients: The French CARENFER Prospective Study. ESC Heart Failure. 9(2). 874–884. 24 indexed citations
6.
Valentin, Simon, Olivier Sitbon, Antoine Beurnier, et al.. (2021). Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs. European Respiratory Journal. 58(5). 2004066–2004066. 11 indexed citations
7.
Boucly, Athénaïs, Jason Weatherald, Laurent Savale, et al.. (2021). External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. European Respiratory Journal. 59(6). 2102419–2102419. 100 indexed citations
8.
Guillaume, Maéva, Jean‐Etienne Ricci, François Roubille, et al.. (2021). Non-Alcoholic Fatty Liver Disease and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Practical Issues. ESC Heart Failure. 8(2). 789–798. 33 indexed citations
9.
Jaffuel, Dany, Erika Nogué, Philippe Berdagué, et al.. (2021). Sacubitril-Valsartan Initiation in Chronic Heart Failure Patients Impacts Sleep Apnea: The ENTRESTO-SAS Study. ESC Heart Failure. 8(4). 2513–2526. 22 indexed citations
10.
Picard, François, et al.. (2021). Clinical Profile and Midterm Prognosis of Left Ventricular Thrombus in Heart Failure. ESC Heart Failure. 8(2). 1333–1341. 25 indexed citations
11.
Henrot, Pauline, Valérie Jolivel, Hamid Rezvani, et al.. (2020). Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis. Journal of Investigative Dermatology. 140(7). 1427–1434.e5. 13 indexed citations
12.
Yanaka, Kenichi, Alicia Guillien, Thibaud Soumagne, et al.. (2020). Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution. European Respiratory Journal. 55(6). 1902418–1902418. 16 indexed citations
13.
Fiore, Mathieu, Chloé James, C. Mouton, et al.. (2014). Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: A single-center experience. Journal of Thoracic and Cardiovascular Surgery. 148(6). 3119–3125.e1. 5 indexed citations
14.
Dournes, Gaël, François Laurent, F Coste, et al.. (2014). Computed Tomographic Measurement of Airway Remodeling and Emphysema in Advanced Chronic Obstructive Pulmonary Disease. Correlation with Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 191(1). 63–70. 42 indexed citations
15.
Picard, François, et al.. (2014). The usefulness of FDG PET/CT imaging in suspicion of LVAD infection. Journal of Nuclear Cardiology. 21(4). 845–848. 15 indexed citations
16.
Dournes, Gaël, Michel Montaudon, Claire Dromer, et al.. (2013). Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. European Radiology. 24(1). 42–51. 120 indexed citations
17.
Ploux, Sylvain, Hélène Verdoux, Zachary I. Whinnett, et al.. (2012). Depression and Severe Heart Failure: Benefits of Cardiac Resynchronization Therapy. Journal of Cardiovascular Electrophysiology. 23(6). 631–636. 6 indexed citations
18.
Picard, François, Pierre Bordachar, & Pierre Dos Santos. (2008). Suivi à distance des patients en insuffisance cardiaque. Journal of Thoracic and Cardiovascular Surgery. 4(2). 104–111. 2 indexed citations
19.
Picard, François. (1991). Keith HOWARD. Bands, Songs and Shamanistic Rituals : Folk Music in Korean Society. Seoul : Royal Asiatic Society, Korea Branch, 1989. 291–292. 8 indexed citations
20.
Picard, François. (1965). Ledermann S., Alcool, alcoolisme, alcoolisation. Tome II : Mortalité, morbidité, accidents du travail.. Persée (Ministère de lEnseignement supérieur et de la Recherche). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026